Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Lam Research Corp., consolidated cash flow statement

US$ in thousands

12 months ended:	Jun 30, 2024	Jun 25, 2023	Jun 26, 2022	Jun 27, 2021	Jun 28, 2020	Jun 30, 2019
Net income	3,827,772)	4,510,931)	4,605,286)	3,908,458)	2,251,753)	2,191,430)
Depreciation and amortization	359,699)	342,432)	333,739)	307,151)	268,525)	309,281)
Deferred income taxes	(198,981)	(172,061)	(257,438)	(151,477)	(17,777)	(4,980)
Equity-based compensation expense	293,058)	286,600)	259,064)	220,164)	189,197)	187,234)
Other, net	10,243)	52,298)	(44,751)	(17,392)	6,628)	1,524)
Accounts receivable, net of allowance	303,443)	1,452,256)	(1,287,680)	(928,928)	(641,827)	732,138)
Inventories	528,723)	(961,968)	(1,351,344)	(792,591)	(411,608)	281,355)
Prepaid expenses and other assets	(15,535)	136,016)	(53,121)	(59,189)	(14,354)	(17,864)
Trade accounts payable	125,939)	(522,200)	167,884)	184,615)	208,478)	(131,472)
Deferred profit	(277,440)	163,467)	604,573)	508,008)	76,207)	(178,074)
Accrued expenses and other liabilities	(304,652)	(108,833)	123,462)	409,344)	211,229)	(194,559)
Changes in operating asset and liability accounts	360,478)	158,738)	(1,796,226)	(678,741)	(571,875)	491,524)
Adjustments to reconcile net income to net cash provided by operating activities	824,497)	668,007)	(1,505,612)	(320,295)	(125,302)	984,583)
Net cash provided by operating activities	4,652,269)	5,178,938)	3,099,674)	3,588,163)	2,126,451)	3,176,013)
Capital expenditures and intangible assets	(396,670)	(501,568)	(546,034)	(349,096)	(203,239)	(303,491)
Business acquisitions, net of cash acquired	—)	(119,955)	—)	—)	—)	—)
Purchases of available-for-sale securities	—)	—)	(567,819)	(3,389,388)	(2,897,627)	(2,930,049)
Proceeds from maturities of available-for-sale securities	34,336)	91,295)	190,269)	2,381,758)	1,647,379)	466,539)
Proceeds from sales of available-for-sale securities	3,430)	6,837)	1,543,434)	1,472,152)	1,235,248)	1,137,302)
Other, net	(11,710)	(11,171)	(7,575)	(42,155)	(25,845)	(7,355)
Net cash (used for) provided by investing activities	(370,614)	(534,562)	612,275)	73,271)	(244,084)	(1,637,054)
Principal payments on long-term debt and finance lease obligations and payments for debt issuance costs	(256,104)	(23,206)	(11,889)	(862,060)	(667,537)	(117,653)
Net proceeds from issuance of long-term debt	—)	—)	—)	—)	1,974,651)	2,476,720)
Net proceeds (repayment) from commercial paper	—)	—)	—)	—)	—)	(361,754)
Proceeds from borrowings on revolving credit facility	—)	—)	—)	—)	1,250,000)	—)
Repayment of borrowings on revolving credit facility	—)	—)	—)	—)	(1,250,000)	—)
Treasury stock purchases	(2,842,807)	(2,017,012)	(3,865,663)	(2,697,704)	(1,369,649)	(3,780,611)
Dividends paid	(1,018,915)	(907,907)	(815,290)	(726,992)	(656,838)	(678,348)
Reissuances of treasury stock related to employee stock purchase plan	119,966)	109,899)	108,178)	97,764)	85,439)	77,961)
Proceeds from issuance of common stock	15,553)	11,111)	5,682)	24,123)	8,084)	6,813)
Other, net	(13,543)	(3,552)	45)	(2,113)	1,920)	(13,208)
Net cash used for financing activities	(3,995,850)	(2,830,667)	(4,578,937)	(4,166,982)	(623,930)	(2,390,080)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(22,374)	128)	(30,227)	7,215)	(2,750)	(4,041)
Net change in cash, cash equivalents and restricted cash	263,431)	1,813,837)	(897,215)	(498,333)	1,255,687)	(855,162)
Cash, cash equivalents and restricted cash at beginning of year	5,587,372)	3,773,535)	4,670,750)	5,169,083)	3,913,396)	4,768,558)
Cash, cash equivalents and restricted cash at end of year	5,850,803)	5,587,372)	3,773,535)	4,670,750)	5,169,083)	3,913,396)

Based on: 10-K (reporting date: 2024-06-30), 10-K (reporting date: 2023-06-25), 10-K (reporting date: 2022-06-26), 10-K (reporting date: 2021-06-27), 10-K (reporting date: 2020-06-28), 10-K (reporting date: 2019-06-30).

Download chart

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Lam Research Corp. net cash provided by operating activities increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.
Net cash (used for) provided by investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Lam Research Corp. net cash (used for) provided by investing activities decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.
Net cash used for financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Lam Research Corp. net cash used for financing activities increased from 2022 to 2023 but then slightly decreased from 2023 to 2024 not reaching 2022 level.

Lam Research Corp. (NASDAQ:LRCX)

Cash Flow Statement